What if we could save lives with 3D-printed, implantable tissues? Trestle Biotherapeutics is using cutting-edge 3D printing and stem cell bioengineering to develop functional kidney tissue. This pioneering approach could transform care for the 800 million people globally suffering from chronic kidney disease. By creating bioengineered tissues that mimic real kidney function, Trestle is working toward reducing the need for dialysis and offering a revolutionary solution for kidney transplants. Tap the link in our bio to find out more. #MIP2024